Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
US7678363B2 · kind B2 · utility
11Cited by
86References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2006 |
| Grant date | Mar 16, 2010 |
| Priority date | — |
| Expiry date | Oct 8, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.